MedWatch

Italian hearing aid retailer disappoints with growth prognosis

Amplifon's long-term guidance has disappointed the market.

Photo: Jens Dresling

Hearing aid retailer Amplifon, which is based in Italy, has released new long-term sales guidance on Monday in connection with a capital market day at the company.

The report proved disappointing reading for the market, even though the company still expects significant growth in 2022 and 2023.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs